Tuesday, December 28, 2021

🥁 Axios PM: Stores' unhappy returns

Plus: Botox is back | Tuesday, December 28, 2021
 
Axios Open in app View in browser
 
Presented By Abbott
 
Axios PM
By Mike Allen ·Dec 28, 2021

Good afternoon: Today's PM — edited by Justin Green — is 363 words, a 1.5-minute read.

 
 
1 big thing: Stores' unhappy returns
Illustration: Shoshana Gordon/Axios

Returns of unwanted gifts are getting so expensive for retailers that increasingly their answer is: Keep it! We'll give you the refund anyway.

  • The return of a $50 item is expected to cost merchants an average of $33 this season, up 59% from 2020, returns processor Optoro tells Axios' Nathan Bomey, soon to be of Axios Closer fame.

Three in 10 online purchases are returned, according to CBRE Supply Chain.

  • Returns are often discarded, donated or repurposed for sale through alternate channels.
  • That's why some retailers, notably Amazon, are taking the "keep it" approach — because the return would cost too much to process, Optoro CEO Tobin Moore tells Axios.

But don't try to game the system to get free stuff.

What's next: A rising number of shoppers are returning goods bought online to physical stores, The Wall Street Journal reports.

  • Retailers are encouraging it — so they can "make returned products quickly available for resale to offset supply-chain snarls and adjust to rising e-commerce sales."

Share this story.

Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 
2. Vax cards, then and now
Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 

A message from Abbott

With Real Madrid, Abbott, it's clear: malnutrition has met its match
 
 

A brighter, sustainable future starts with good health. And good health starts with good nutrition of the body and mind.

The goal: Reduce malnutrition, promote education and share the values of sport in every region of the world over the next decade.

The work begins now.

 
 
3. Catch up quick
People wait in line at a testing site to receive a free COVID-19 PCR test in Farragut Square in D.C. Photo: Anna Moneymaker/Getty Images
  1. The CDC slashed its estimate of Omicron case prevalence after it ultimately discovered fewer cases as more data came in. Go deeper.
  2. The NBA is cutting COVID isolations from 10 to 6 days, as long as people are asymptomatic and meet other testing requirements. Go deeper.
  3. The CDC is actively investigating or observing 86 cruise ships following COVID outbreaks on board. Go deeper.
  4. Drug regulators in India authorized two COVID vaccines, Corbevax and Covovax, for emergency use. Go deeper.
Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 
4. 1 for the road: Botox is back
Data: AbbVie/Allergan documents; Chart: Jared Whalen/Axios

The rollout of COVID vaccines and a larger, younger crowd willing to try Botox injections have led to swelling demand in dermatology offices and medical spas, reports Axios' Bob Herman.

Between the lines: Patients getting Botox are now younger on average. "And by younger I mean closer to 40 versus 50," said Carrie Strom, a senior VP at AbbVie, which owns the company that makes Botox.

Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 

A message from Abbott

Diabetes care that's connected to your phone
 
 

Abbott's FreeStyle Libre 2, an integrated continuous glucose monitoring (iCGM) system now has FDA clearance for iPhone and Android apps.

Why it's important: You can monitor your glucose through Apple iOS and Android apps, your data is just a simple scan away to get your latest glucose values.

 
HQ
Like this email style and format?
Bring the strength of Smart Brevity® to your team — more effective communications, powered by Axios HQ.
 

Axios thanks our partners for supporting our newsletters. If you're interested in advertising, learn more here.
Sponsorship has no influence on editorial content.

Axios, 3100 Clarendon B‌lvd, Suite 1300, Arlington VA 22201
 
You received this email because you signed up for newsletters from Axios.
Change your preferences or unsubscribe here.
 
Was this email forwarded to you?
Sign up now to get Axios in your inbox.
 

Follow Axios on social media:

Axios on Facebook Axios on Twitter Axios on Instagram
 
 
                                             

No comments:

Post a Comment

Quant King’s Next Big AI Play

The unexpected places you need to look…   December 21, 2024 Quant King’s Next Big AI Play By Michael Salvatore, ...